Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 2/20 | 0.46 |
| ▸ | PPARA | Q07869 | 2/20 | 0.46 |
| ▸ | GBA1 | P04062 | 1/20 | 0.44 |
| ▸ | UGCG | Q16739 | 1/20 | 0.44 |
| ▸ | GBA2 | Q9HCG7 | 1/20 | 0.44 |
| ▸ | IDO1 | P14902 | 2/20 | 0.41 |
| ▸ | AGXT | P21549 | 2/20 | 0.41 |
| ▸ | HTT | P42858 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.39 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | MAOB | P27338 | 3/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11737547 | 0.87 | GBA1 (0.45) | GBA1UGCGGBA2IDO1AGXT | |
| SCHEMBL16674306 | 0.85 | TDP1 (0.41) | IDO1MAPK1CA1CA2 | |
| SCHEMBL9452770 | 0.81 | SLC6A2 (0.53) | IDO1AGXTHTTHPGDKMT2A | |
| SCHEMBL9452755 | 0.81 | SLC6A2 (0.53) | IDO1AGXTHTTHPGDKMT2A | |
| SCHEMBL14420303 | 0.80 | PPARG (0.49) | PPARGPPARAGBA1UGCGGBA2 | |
| SCHEMBL16674426 | 0.78 | TDP1 (0.36) | IDO1HTTHPGDMAPK1CA1 | |
| SCHEMBL19771036 | 0.77 | ADRB2 (0.40) | IDO1KMT2AMAPK1LMNA | |
| SCHEMBL2414665 | 0.77 | IDO1 (0.45) | IDO1KMT2AMAOBLMNAAPP | |
| SCHEMBL10127339 | 0.76 | HTT (0.47) | PPARGPPARAIDO1AGXTHTT | |
| SCHEMBL14763820 | 0.76 | TSHR (0.56) | HTTSMN1; SMN2CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7265086-B2 | Glycopeptide carboxy-saccharide derivatives | THERAVANCE, INC. (US) | 2007-09-04 | — | — | US | disclosed |
| US-20070042942-A1 | Glycopeptide carboxy-saccharide derivatives | THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC | 2007-02-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070042942-A1 | Glycopeptide carboxy-saccharide derivatives | CSGALNACT1, FUT6, OGT | PPARG 3293/4885PPARA 3951/4885GBA1 379/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.